Information on the impact of coronavirus (COVID-19) on patient care and School/University operations. Plus, resources for the Penn Dental Medicine community and alumni.
Home // Continuing Education // Online Classroom // State Required Continuing Education
Dr. Elliot Hersh will explore the pharmacokinetics of Liposomal bupivacaine (Exparel®) and discuss its cost-effectiveness in the control of pain in dental outpatients. He will also present evidence-based data that supports or does not support some serious adverse drug interactions involving NSAID analgesic agents.
Dr. Elliot Hersh will discuss evidence based guidelines for pain management after third molar (wisdom teeth) extractions and present meta-analysis data for various analgesics in both dental pain and other post-surgical pain models.
